GPT and Hypofibrinogenemia: Nineteen (59.4%) patients had elevated fasting triglyceride (defined as > 2.99 mmol/L) with a median of 3.90 mmol/L, 71.9% had hypofibrinogenemia (defined as < 1.5 g/L) with a median of 1.05 g/L, and 96.9% had transaminitis (defined as above the laboratory reference range) with a median AST of 612 U/L (range 54 – 11,614 U/L) and ALT of 351 U/L (range 51 – 7,361 U/L).